DJIA 17,827.75 12.81 0.07%
NASDAQ 4,787.32 29.07 0.61%
S&P 500 2,072.83 5.80 0.28%
market minute promo

Celgene (NASDAQ: CELG)

112.61 1.54 (1.39%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $112.61 1.39%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $111.46
Previous Close $111.07
Daily Range $109.20 - $112.82
52-Week Range $66.85 - $112.82
Market Cap $89.9B
P/E Ratio 58.15
Dividend (Yield) $0.00 (0.0%)
Volume 3,269,754
Average Daily Volume 5,534,418
Current FY EPS $3.26





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary

3 Biotech Growth Stocks You Can Buy Right Now

These three biotech growth stocks may have already delivered impressive gains to investors, but there could still be plenty of room left for them to head even higher.

Celgene Shares Could Soon Hit $140 Thanks To Exceptional Earnings Growth

Mixed Readings For Biotech Short Interest

Rolling With Biotech's Regulatory Punches: Chen Lin

Cramer: Workday, Netflix, Amazon Struggle as Momentum Lags

RBC Has Three Top Biotech Picks for Year End and 2015

Celgene's PDE4 Inhibitor Otezla Gets Positive CHMP Opinion - Analyst Blog

Jim Cramer's 'Mad Money' Recap: Here's Where Money Managers Should Put Their Money

3 Biotech Stocks That Could Soar Even Higher

Three Motley Fool analysts weigh in on high-flying biotech stocks that they think could continue climbing.

Jim Cramer on the Markets: Remember Investors, We're Not China

See More CELG News...

CELG's Top Competitors

CELG $112.61 (1.39%)
Current stock: CELG
GILD $100.30 (-0.80%)
Current stock: GILD
BIIB $304.92 (-0.16%)
Current stock: BIIB
$0.00 (0.00%)
Current stock: